Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient

Abstract excerpt

We have recently published on the limited effectiveness of sirolimus as a treatment option for hypoglycaemia as a consequence of hyperinsulinism. Our data oppose the view that mTOR inhibitors provide new opportunities for the treatment of patients with hyperinsulinism. We are not convinced by the argument that any benefit for some patients outweighs the potential and later long-term problems that accompany mTOR...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hyperglycemia and glycemic control in critically ill and hospitalized patients
• Share to Neuroendocrine Tumor Research Advances
• Share to Pancreatic function and diabetes